Patient Guide: Evaluation of Two Dose Levels of Quizartinib as Maintenance in FLT3-ITD (+) Acute Myeloid Leukemia Patients in Complete Remission

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 57 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT06824168
Status: 🟢 Enrolling Now
Condition: Acute Myeloid Leukemia, Leukemia
Phase: PHASE2

Where You Can Participate

This study is available at 57 locations across the country.

Top locations include:
  • • Baltimore, Maryland
  • • Worcester, Massachusetts
  • • Buffalo, New York
  • • And 54 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

Evaluation of Two Dose Levels of Quizartinib as Maintenance in FLT3-ITD (+) Acute Myeloid Leukemia Patients in Complete Remission - Join Clinical Trial NCTNCT06824168

How to Join This Clinical Trial - NCTNCT06824168

Learn how to participate in this PHASE2 trial studying an investigational therapy for Acute Myeloid Leukemia, Leukemia. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Acute Myeloid Leukemia, Leukemia. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Acute Myeloid Leukemia, Leukemia
Treatment Being Tested
Investigational treatment
Study Phase
PHASE2 - Safety and effectiveness study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT06824168 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 57 locations. Find a study site near you:

Clinical Research Site

Baltimore, Maryland 21287 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Worcester, Massachusetts 01655 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Buffalo, New York 14263 - United States

Status: WITHDRAWN

Clinical Research Site

New York, New York 10021-9800 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Valhalla, New York 10595 - United States

Status: WITHDRAWN

Clinical Research Site

Westbury, New York 11590 - United States

Status: RECRUITING

Clinical Research Site

Easton, Pennsylvania 18045 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Houston, Texas 77030 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Houston, Texas 77030 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Adelaide, - Australia

Status: NOT_YET_RECRUITING

And 47 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE2 clinical trial for Acute Myeloid Leukemia, Leukemia:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships